These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33177101)

  • 1. Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort'.
    Ruyssen-Witrand A; Soubrier M; Basch A; Truchetet ME; Seror R
    Ann Rheum Dis; 2023 Feb; 82(2):e32. PubMed ID: 33177101
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort' by Ruyssen-Witrand
    Ciurea A; Finckh A
    Ann Rheum Dis; 2023 Feb; 82(2):e33. PubMed ID: 33177100
    [No Abstract]   [Full Text] [Related]  

  • 3. Telemedicine in the Management of Patients with Rheumatic Disease during COVID-19 Pandemic: Incidence of Psychiatric Disorders and Fibromyalgia in Patients with Rheumatoid Arthritis and Psoriatic Arthritis.
    Foti R; Amato G; Dal Bosco Y; Longo A; Gagliano C; Falsaperla R; Foti R; Speranza S; De Lucia F; Visalli E
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Online management of rheumatoid arthritis during COVID-19 pandemic.
    Zhang Y; Wang J; Zhao L; Xiao J; Shi Z
    Ann Rheum Dis; 2021 Jan; 80(1):e4. PubMed ID: 32340979
    [No Abstract]   [Full Text] [Related]  

  • 5. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M
    Cacciapaglia F; Manfredi A; Erre G; Piga M; Sakellariou G; Viapiana O; Gremese E; Spinelli FR; Atzeni F; Bartoloni E
    Ann Rheum Dis; 2023 Jul; 82(7):e159. PubMed ID: 32933920
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Aydin
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2023 Mar; 82(3):e70. PubMed ID: 33355105
    [No Abstract]   [Full Text] [Related]  

  • 7. The psychological impact of the COVID-19 pandemic on Dutch people with and without an inflammatory rheumatic disease.
    Koppert TY; Jacobs JWG; Geenen R
    Rheumatology (Oxford); 2021 Aug; 60(8):3709-3715. PubMed ID: 33313870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha
    Dejaco C; Bijlsma JW; Buttgereit F
    Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796
    [No Abstract]   [Full Text] [Related]  

  • 9. Correspondence to 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'.
    Schulze-Koops H; Skapenko A; Krause A; Krueger K; Lorenz HM; Sewerin P; Specker C; Wagner UG; Voormann A; Mueller-Ladner U; Voll RE
    Ann Rheum Dis; 2023 Jan; 82(1):e1. PubMed ID: 33127664
    [No Abstract]   [Full Text] [Related]  

  • 10. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.
    Al Nokhatha S; MacEoin N; Conway R
    Ann Rheum Dis; 2021 Oct; 80(10):e170. PubMed ID: 33509797
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of the COVID-19 pandemic on recruitment to clinical research studies in rheumatology.
    Mirza M; Siebert S; Pratt A; Insch E; McIntosh F; Paton J; Wright C; Buckley CD; Isaacs J; McInnes IB; Raza K; Falahee M
    Musculoskeletal Care; 2022 Mar; 20(1):209-213. PubMed ID: 33938621
    [No Abstract]   [Full Text] [Related]  

  • 12. Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and Behaving?
    Adnine A; Soussan I; Nadiri K; Coulibaly S; Berrada K; Najdi A; Abourazzak FE
    Curr Rheumatol Rev; 2021 Aug; 17(3):318-326. PubMed ID: 33371850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?
    Batu ED; Erden A
    Int J Rheum Dis; 2023 Aug; 26(8):1435-1439. PubMed ID: 37527023
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.
    Gupta L; Misra DP; Agarwal V; Balan S; Agarwal V
    Ann Rheum Dis; 2021 Jan; 80(1):e1. PubMed ID: 32299795
    [No Abstract]   [Full Text] [Related]  

  • 15. Mental Health Problems Experienced by Patients with Rheumatic Diseases During COVID-19 Pandemic.
    Adnine A; Nadiri K; Soussan I; Coulibaly S; Berrada K; Najdi A; Abourazzak FE
    Curr Rheumatol Rev; 2021; 17(3):303-311. PubMed ID: 33504309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to: 'Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis
    Schulze-Koops H; Krueger K; Specker C
    Ann Rheum Dis; 2021 Apr; 80(4):e61. PubMed ID: 32475833
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves.
    Drumez E; Richez C; Bebear L; Herasse M; Flipo RM; Marotte H; Georgin-Lavialle S; Seror R; Pertuiset E; Avouac J; Chazerain P; Roux N; Pham T; Dernis E; Uzunhan Y; Servettaz A; El Mahou S; Cacoub P; Hamidou M; Fautrel B; Thomas T; Hachulla E; ;
    Joint Bone Spine; 2023 Sep; 90(5):105605. PubMed ID: 37399939
    [No Abstract]   [Full Text] [Related]  

  • 18. The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases.
    Xiao F; Han M; Zhu X; Tang Y; Huang E; Zou H; Jiang Q; Lu L
    Mod Rheumatol; 2021 Sep; 31(5):927-932. PubMed ID: 33427554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the true incidence of COVID-19 in patients with rheumatic diseases?
    Favalli EG; Ingegnoli F; Cimaz R; Caporali R
    Ann Rheum Dis; 2021 Feb; 80(2):e18. PubMed ID: 32321723
    [No Abstract]   [Full Text] [Related]  

  • 20. Rheumatic disease and COVID-19.
    Liew JW; Graef ER
    Ann Rheum Dis; 2021 Mar; 80(3):e43. PubMed ID: 32651196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.